Evaluation of Polyflex Stenting in Esophageal Cancer Patients

Completed

Conditions studied: Esophageal Cancer

In brief

To evaluate the effectiveness of an esophageal stent as a way to maintain nutrition during radiation and/or chemotherapy treatment.

Key facts

Study ID

NCT00727376

Run by

University of Louisville

People needed

26

Starts

2008-03-01

Expected to finish

2011-02-01

Last updated by the study team

2020-08-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older
• Willing and able to provide informed consent
• Willing to comply with follow-up requirements
• Biopsy-confirmed esophageal cancer (adenocarcinoma or squamous cell carcinoma) in mid or distal esophagus (clinical stage 3 or less)
• Indicated for chemotherapy and/or radiation therapy
• Ability to dilate stricture to 15mm diameter at extent of disease evaluation
• Placement of at least 18 x 23mm diameter and 120mm length PolyFlex stent

You may not qualify if…

• Patients contraindicated for endoscopy
• Patients with prior esophageal stent placements
• Advance stage of disease, greater than T3 tumor or M1 disease

Where it is running

• University of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.